These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10342793)

  • 1. Low dose bendrofluazide (1.25 mg) effectively lowers blood pressure over 24 h: results of a randomized, double-blind, placebo-controlled crossover study.
    Wiggam MI; Bell PM; Sheridan B; Walmsley A; Atkinson AB
    Am J Hypertens; 1999 May; 12(5):528-31. PubMed ID: 10342793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients.
    Girvin B; Johnston GD
    J Hypertens; 1998 Jul; 16(7):1049-54. PubMed ID: 9794747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension.
    Harper R; Ennis CN; Sheridan B; Atkinson AB; Johnston GD; Bell PM
    BMJ; 1994 Jul; 309(6949):226-30. PubMed ID: 7818648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group.
    Lacourcière Y; Pool JL; Svetkey L; Gradman AH; Larochelle P; de Champlain J; Smith WB
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):454-61. PubMed ID: 9607384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide.
    Vanmolkot FH; de Hoon JN; van de Ven LL; Van Bortel LM
    J Hum Hypertens; 1999 Aug; 13(8):559-63. PubMed ID: 10455479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension.
    Isles CG; Kitchin NR
    J Hum Hypertens; 1999 Jan; 13(1):69-73. PubMed ID: 9928755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of antihypertensive treatment on cognitive function: results from the HOPE study.
    Starr JM; Whalley LJ; Deary IJ
    J Am Geriatr Soc; 1996 Apr; 44(4):411-5. PubMed ID: 8636587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
    Hosie J; Nasar MA; Belgrave GP; Walters EG
    Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period.
    Eames PJ; Robinson TG; Panerai RB; Potter JF
    Cerebrovasc Dis; 2005; 19(4):253-9. PubMed ID: 15731556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
    Carlsen JE; Køber L; Torp-Pedersen C; Johansen P
    BMJ; 1990 Apr; 300(6730):975-8. PubMed ID: 2344503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.
    White WB; Mansoor GA; Pickering TG; Vidt DG; Hutchinson HG; Johnson RB; Noveck R
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):806-14. PubMed ID: 10480474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
    Zanchetti A
    J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
    Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
    J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The systemic haemodynamic and cerebral autoregulatory effects of bendrofluazide in the subacute post-stroke period.
    Eames PJ; Robinson TG; Panerai RB; Potter JF
    J Hypertens; 2004 Oct; 22(10):2017-24. PubMed ID: 15361775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.